Picture loading failed.

Anti-MS4A1;CD3E therapeutic antibody (Pre-made Odronextamab biosimilar,Bispecific mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).



Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-391-1mg 1mg Inquiry
GMP-Bios-ab-391-10mg 10mg Inquiry
GMP-Bios-ab-391-100mg 100mg Inquiry
GMP-Bios-ab-391-xmg >100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-MS4A1;CD3E therapeutic antibody (Pre-made Odronextamab biosimilar,Bispecific mAb)
INN Name Odronextamab
TargetMS4A1;CD3E
FormatBispecific mAb
DerivationBispecific antibody
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa;Kappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusActive
100% SI StructureNone;None
99% SI StructureNone;None
95-98% SI StructureNone;None
Year Proposed2019
Year Recommended2020
CompaniesRegeneron Pharmaceuticals
Conditions Approvedna
Conditions ActiveFollicular lymphoma;B-cell lymphoma;Chronic lymphocytic leukaemia;Non-Hodgkin's lymphoma;Precursor B-cell lymphoblastic leukaemia-lymphoma
Conditions Discontinuedna
Development Techna